Physiology Myocardial Oxygen Supply and Demanda,b.

Slides:



Advertisements
Similar presentations
CORONARY CARE UNIT (CCU)
Advertisements

Mechanical Support for Acute Cardiogenic Shock
Innovative Minimally Invasive Circulatory Assist Device.
on behalf of the TOTAL Investigators
Glucose – Insulin – Potassium Study in Patients with ST Elevation Myocardial Infarction without Signs of Heart Failure Presented at American College of.
Clinical Trial Results. org Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention.
Randomized Angioplasty Beta Blocker Intracoronary Trial II (RABBIT II) Presented at The American Heart Association Scientific Session 2006 Presented by.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 53 Management of ST-Elevation Myocardial Infarction.
ST-Elevation Myocardial Infarction & Cardiogenic Shock - What Should We Do? Advanced Angioplasty 2008 Dan Blackman Leeds General Infirmary.
Silent Ischemia STABLE CAD
Occluded Artery Trial (OAT) Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman OAT Trial.
Mechanical Circulatory Support Cardiogenic Shock Post AMI
Intra-Aortic Balloon Pump What it is and what it does
AB 1/03 Non-Coronary Intervention Circulatory Support Advanced Angioplasty 2003 Andreas Baumbach Bristol Royal Infirmary.
A Prospective, Randomized Evaluation of Supersaturated Oxygen Therapy After Percutaneous Coronary Intervention in Acute Anterior Myocardial Infarction.
Ihab Alomari, MD, FACC Assistant professor – Interventional Cardiology University of California, Irvine Division of Cardiology Cath Lab Essentials : LV.
Early Management of AMI Key points Recognition of symptoms by the patient and prompt seeking of medical attention Rapid deployment of emergency medical.
? What more will it take to turn the tide of treatment for angina patients from a PCI-first to an optimal medical therapy– first approach? 1.
IABP用于高危PCI有价值吗? Is IABP Valuable for High-Risk PCI?
Types of Hemodynamic Support in the Cath Lab.
Conflict of Interest Baxter Research Grant Medtronic Research Grant
IABP-SHOCK II Score Stratifies Patient Risk in CS after AMI
Debate: Prophylactic Support Increases Risk With Little Benefit
Percutaneous Coronary Interventions for Patients with Relative Contra-indications: Severely Depressed Left Ventricular Function Great Wall International.
Improving Outcomes in Cardiogenic Shock
Nat. Rev. Cardiol. doi: /nrcardio
Management of ST-Elevation Myocardial Infarction
Mechanical circulatory support
Impella 2.5® Device Is Associated with Improved Survival in AMICS
Balloon-pump assisted Coronary Intervention Study (BCIS-1):
Mortality Related to Periprocedural MI in CTO-PCI
Effect of Obesity on In-Hospital Mortality in Patients with Cardiogenic Shock Complicating AMI Obesity is paradoxically associated with favorable mortality.
Acute Heart Failure.
Cardiogenic Shock.
The Clinical Enigma of Cardiogenic Shock
Unstable Angina and Non–ST Elevation Myocardial Infarction
Angiotensin as a Vasopressor in Vasodilatory Shock
Dual Goals for the Management of Stable Ischemic Heart Disease (SIHD)
Introduction Antiplatelet Agents ADP Receptor Antagonists.
ATLANTIC Trial design: Participants with STEMI being transported for primary PCI were randomized in the ambulance to ticagrelor 180 mg (n = 909) vs. placebo.
Neurostimulation for the Management of Medication-Resistant Epilepsy
Percutaneous Mechanical Circulatory Support Devices
STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES
LEVO-CTS Trial design: Patients undergoing cardiac surgery with the use of cardiopulmonary bypass were randomized to infusion of levosimendan 0.2 µg/kg/min.
When Would You Use Single Inhaler Triple Therapy in COPD?
Improving Risk Assessment and Early Diagnosis in PAH
Treating Vasodilatory Shock in the ICU
Activity Goals. Activity Goals Case Presentation.
Considerations for Percutaneous Coronary Intervention (PCI)
Novel Therapies for the Treatment of MS
Comparison of US and European Guidelines Oral Antiplatelet Therapy in Primary PCI/STEMI.
Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.
A Hard Look at Cardiogenic Shock: IABP-SHOCK II Revisited
Atorvastatin for Reduction of Myocardial Damage During Angioplasty
Remote Patient Management:
Mechanical Circulatory Support Devices HOSEIN PASANDI.
BASKET-SAVAGE Trial design: Patients with a SVG lesion were randomized to a DES (Taxus Liberte; n = 89) versus a BMS (Liberte; n = 84). All patients were.
Nat. Rev. Cardiol. doi: /nrcardio
NIPPON Trial design: Patients undergoing percutaneous coronary intervention were randomized to short-term dual antiplatelet therapy (DAPT) (6 months; n.
American College of Cardiology Presented by Dr. Michel R. Le May
Figure 4 Observational studies on multiple treatment strategies
CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so.
Saving the Day.
Maintenance of Long-Term Clinical Benefit with
IMPRESS Trial design: Patients undergoing primary PCI for STEMI and cardiogenic shock were randomized in a 1:1 to either Impella CP or IABP. They were.
Evaluating the Science of Cardiogenic Shock
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
Trends in Early Aspirin Use Among Patients With Acute Myocardial Infarction in China, 2001–2011: The China PEACE-Retrospective AMI Study Yan Gao, Frederick.
TYPHOON Trial Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at.
Translating Data From Trial to Practice
Presentation transcript:

Physiology Myocardial Oxygen Supply and Demanda,b

Goals of Hemodynamic Support During High-Risk PCI

Percutaneous Cardiac Assist Devices

Percutaneous Cardiac Assist Devices (cont)

Pressure vs Flow Devices Mechanisms

Assist Treatments Effect on Myocardial Oxygen Demand

Complementary Mechanisms

Patient Selection IABPa

IABP Randomized Trials CRISP AMI

IABP Randomized Trials CRISP AMI Substudy

IABP Randomized Trials BCIS-1

Patient Selection IABP (cont)

IABP in MI SHOCK and SHOCK II Trials

AFP Patients with ST-Segment Elevation AMI and/or Cardiogenic Shocka

Individualizing Cardiac Support Therapy

Individualizing Cardiac Support Therapy (cont)

IABP vs AFP vs CFP Typical Practice Scenarios

Conclusions

Abbreviations

Abbreviations (cont)

Abbreviations (cont)

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)